R-Biopharm introduces a Therapeutic Drug Monitoring (TDM) and invites you to take part in an online presentation to be held on Wednesday, 21st of April at 4 pm (CEST).
The last few years Therapeutic Drug Monitoring has focused on the use of the biologicals in Rheumatology and mostly Inflammatory Bowel Disease.
Dermatology is the third application for biologicals. The treatment of psoriasis with biologicals is possible since a few years and is covered by a wide range of classes of biologicals. A survey performed by Lisa Schots, Lynda Grine, Rani Soenen and Jo Lambert had interesting results on how the dosing of biologicals is currently applied in clinical practice. As a result, more than 80% of the participants reported interest in education on TDM in Dermatology.
With this online seminar R-Biopharm AG will contribute to the education in TDM in Dermatology.
In this online seminar Dr. Lynda Grine, trained biochemist and postdoctoral researcher, and Professor Dr Jo Lambert, dermatologist and key opinion leader in psoriasis, both active at the Ghent University Hospital in Belgium, will present how TDM can be implemented in Dermatology based on their research and experiences.
R-Biopharm AG and apDia bvba are licensed by the KU Leuven to commercialize their monoclonal antibodies.